Consensus recommendations for the use of automated insulin delivery technologies in clinical practice
M Phillip, R Nimri, RM Bergenstal… - Endocrine …, 2023 - academic.oup.com
The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …
Patient and general public attitudes towards clinical artificial intelligence: a mixed methods systematic review
AT Young, D Amara, A Bhattacharya… - The lancet digital health, 2021 - thelancet.com
Artificial intelligence (AI) promises to change health care, with some studies showing proof
of concept of a provider-level performance in various medical specialties. However, there …
of concept of a provider-level performance in various medical specialties. However, there …
High-performance medicine: the convergence of human and artificial intelligence
EJ Topol - Nature medicine, 2019 - nature.com
The use of artificial intelligence, and the deep-learning subtype in particular, has been
enabled by the use of labeled big data, along with markedly enhanced computing power …
enabled by the use of labeled big data, along with markedly enhanced computing power …
[HTML][HTML] Management of diabetes and hyperglycaemia in the hospital
FJ Pasquel, MC Lansang, K Dhatariya… - The lancet Diabetes & …, 2021 - thelancet.com
Hyperglycaemia in people with and without diabetes admitted to the hospital is associated
with a substantial increase in morbidity, mortality, and health-care costs. Professional …
with a substantial increase in morbidity, mortality, and health-care costs. Professional …
Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial
AB Daly, CK Boughton, M Nwokolo, S Hartnell… - Nature medicine, 2023 - nature.com
In adults with type 2 diabetes, the benefits of fully closed-loop insulin delivery, which does
not require meal bolusing, are unclear. In an open-label, single-center, randomized …
not require meal bolusing, are unclear. In an open-label, single-center, randomized …
Long-term unsupervised mobility assessment in movement disorders
Mobile health technologies (wearable, portable, body-fixed sensors, or domestic-integrated
devices) that quantify mobility in unsupervised, daily living environments are emerging as …
devices) that quantify mobility in unsupervised, daily living environments are emerging as …
Advances in technology for management of type 1 diabetes
RW Beck, RM Bergenstal, LM Laffel, JC Pickup - The Lancet, 2019 - thelancet.com
Technological advances have had a major effect on the management of type 1 diabetes. In
addition to blood glucose meters, devices used by people with type 1 diabetes include …
addition to blood glucose meters, devices used by people with type 1 diabetes include …
[HTML][HTML] Continuous glucose monitoring sensors for diabetes management: a review of technologies and applications
By providing blood glucose (BG) concentration measurements in an almost continuous-time
fashion for several consecutive days, wearable minimally-invasive continuous glucose …
fashion for several consecutive days, wearable minimally-invasive continuous glucose …
[PDF][PDF] 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea
By providing blood glucose (BG) concentration measurements in an almost continuous-time
fashion for several consecutive days, wearable minimally-invasive continuous glucose …
fashion for several consecutive days, wearable minimally-invasive continuous glucose …